Skip to content
← Back to this collection

PUBLICATIONS · 37306107

Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Cancer Med
Publication date
2023 Jul
First author
Shulman DS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Shulman DS
      type
      Author
    2. name
      Merriam P
      type
      Author
    3. name
      Choy E
      type
      Author
    4. name
      Guenther LM
      type
      Author
    5. name
      Cavanaugh KL
      type
      Author
    6. name
      Kao PC
      type
      Author
    7. name
      Posner A
      type
      Author
    8. name
      Bhushan K
      type
      Author
    9. name
      Fairchild G
      type
      Author
    10. name
      Barker E
      type
      Author
    11. name
      Klega K
      type
      Author
    12. name
      Stegmaier K
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Shulman DS
      type
      Author
    2. name
      Merriam P
      type
      Author
    3. name
      Choy E
      type
      Author
    4. name
      Guenther LM
      type
      Author
    5. name
      Cavanaugh KL
      type
      Author
    6. name
      Kao PC
      type
      Author
    7. name
      Posner A
      type
      Author
    8. name
      Bhushan K
      type
      Author
    9. name
      Fairchild G
      type
      Author
    10. name
      Barker E
      type
      Author
    11. name
      Klega K
      type
      Author
    12. name
      Stegmaier K
      type
      Author
    bibliography ids
    1. nci-bib-7372bd2eb1e18bc4d84043cf
    book metadata
    content sha256
    bf21c0f5048d13a32e1d77ca7c4ede101be7d0428a5f74a8ec130c6fb1c86a04
    document type
    citation
    dois
    1. 10.1002/cam4.6208
    electronic publication date
    display
    2023 Jun 12
    precision
    day
    year
    2023
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:37306107
    immutable id
    pubmed:37306107@bf21c0f5048d13a32e1d77ca7c4ede101be7d0428a5f74a8ec130c6fb1c86a04
    journal
    abbreviation
    Cancer Med
    issn electronic
    2045-7634
    issn print
    Source null
    issue
    14
    name
    Cancer medicine
    nlm unique id
    101595310
    pages
    15207-15216
    volume
    12
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      37306107
      provenance
      batch id
      5329a5d0877ee70ecd11
      provider
      NCBI PubMed ESummary
      record sha256
      aa60cde004258cf593b1b2fcf3a59d90cb45f9f5905c343b0b2f23b6c31d2690
      response sha256
      bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
      retrieved at
      2026-09-09T23:48:15.763286+00:00
      publication date
      display
      2023 Jul
      precision
      month
      year
      2023
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/37306107/
      title
      Phase 2 trial of palbociclib and ganitumab in patients with relapsed Ewing sarcoma.

      Preserved source evidence · Not medical advice